Health Condition 1: H470- Disorders of optic nerve, not elsewhere classified
Conditions
Interventions
Intervention1: Medical treatment with high or megadoses of methylprednisolone: 3 days treatment
Intervention2: Recombinant Human Erythropoietin: 3 days treatment
Control Intervention1: Medical treatme
Sponsors
Aurolab
Eligibility
Inclusion criteria
Inclusion criteria: a) Having indirect traumatic optic neuropathy (with normal eye and fundus exam) b) Trauma to treatment interval of 2 weeks and less
Exclusion criteria
Exclusion criteria: a) Direct optic neuropathy b) Glaucoma c) Any retinopathy d) Globe laceration e) Hypertension f) Polycythaemia g) Creatinine more than 3 mg/dl, h) Patients who have received any other form of treatment for their traumatic optic neuropathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of Participants with Change/Improvement Visual Acuity From the Baseline [Time Frame: Change from baseline at least 3 months after treatment]Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Relative Afferent Pupillary Defect, Color Vision, Side EffectsTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Kowsalya Akkayasamy
Aravind Eye Hospital and Postgraduate Institute of Ophthalmology
Outcome results
None listed